Nektar Therapeutics (NKTR) EPS (Diluted) (2013 - 2026)

Nektar Therapeutics (NKTR) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.75
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.52
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Nektar Therapeutics 1.76 Bn 1.19 Bn 3.16 Mn -1.74

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.74
Dec 31, 2025 -0.02
Sep 30, 2025 -1.85
Jun 30, 2025 -2.78
Mar 31, 2025 -3.30
Dec 31, 2024 2.34
Sep 30, 2024 -2.66
Jun 30, 2024 -3.76
Mar 31, 2024 -2.83
Dec 31, 2023 -3.32
Sep 30, 2023 -3.61
Jun 30, 2023 -4.04
Mar 31, 2023 -10.88
Dec 31, 2022 1.62
Sep 30, 2022 -4.72
Jun 30, 2022 -12.77
Mar 31, 2022 -7.30
Dec 31, 2021 31.00
Sep 30, 2021 -10.57
Jun 30, 2021 -10.30